Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein

Vaccine

Volumn 19, Issue 23-24, 2001, Pages 3154-3163

  Yamada, Tadanori ^a,b   Iwabuki, Hidehiko ^a   Kanno, Takashi ^a   Tanaka, Hiroyuki ^a   Kawai, Tomoji ^a   Fukuda, Hideki ^b   Kondo, Akihiko ^b   Seno, Masaharu ^c   Tanizawa, Katsuyuki ^a   Kuroda, Shun'ichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Atomic force microscopy; HBsAg L particles; Immune responses; Pre S1 region; Yeast derived hepatitis B vaccine

Indexed keywords

DITHIOTHREITOL; GLYCINE CLEAVAGE SYSTEM; HEPATITIS B VACCINE; VIRUS ENVELOPE PROTEIN; VITRONECTIN;

ARTICLE; DRUG POTENCY; HEATING; HEPATITIS B; HEPATITIS B VIRUS; LIVER CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN PURIFICATION; VIRUS ENVELOPE; YEAST CELL;

ANIMALS; CHEMISTRY, PHYSICAL; CIRCULAR DICHROISM; DRUG STABILITY; GENE PRODUCTS, ENV; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; MICE; MICE, INBRED BALB C; MICROSCOPY, ATOMIC FORCE; RECEPTORS, ALBUMIN; ULTRACENTRIFUGATION;

EID: 0035972033     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00017-2     Document Type: Article

References (28)

1. Large surface proteins of hepatitis B virus containing the pre-s sequence
2. Hepatitis B virus contains pre-S gene-encoded domains
3. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: Protective efficacy in chimpanzees
4. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen
5. Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region
6. Efficient expression of genetically engineered hepatitis B virus surface antigen P31 proteins in yeast
7. Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine)
8. Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine)
9. Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): Phase 1, 2 and 3 clinical testing
10. Immunological response to pre-S antigens of the hepatitis B virus
11. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective
12. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus
13. Definition of the primary structure of hepatitis B virus (HBV) pre-S hepatocyte binding domain using random peptide libraries
14. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain
15. Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands
16. Expression of hepatitis B virus middle and large surface antigen genes in Saccharomyces cerevisiae
17. A candidate vaccine for hepatitis B containing the complete viral surface protein
18. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity
19. Hepatitis B virus envelope L protein particles, Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization
20. Recombinant hepatitis B virus surface antigen carrying the pre-S2 region derived from yeast: Purification and characterization
21. Calculation of protein conformation from circular dichroism
22. Expression of hepatitis B virus surface antigen P31 gene in Escherichia coli
23. A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins
24. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): A pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg
25. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles
26. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines
27. Clinical experience with the pre-S1-containing hepatitis B vaccine (HG-3) in different nonresponders groups
28. Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene, a hepatitis B vaccine containing pre-S1, pre-S2 gene products